Connection

David Cole to Single-Chain Antibodies

Back to Details
This is a "connection" page, showing publications David Cole has written about Single-Chain Antibodies.
David Cole
Connection Strength
0.066
Single-Chain Antibodies
  1. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours. Cancer Treat Rev. 2019 Jul; 77:35-43.
    View in: PubMed
    Score: 0.040
  2. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.